Epidemiological characteristics of pulmonary thromboembolism in children: a systematic review and meta-analysis

Jianing Liu1,2,3,4,5, Xiaofeng Ni1,2,3,4,6, Linan Zeng1,2,3,6

  • 1Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University; Children's Medicine Key Laboratory of Sichuan Province, Chengdu, China.

BMJ Open
|March 11, 2026
PubMed

Insights

Pediatric pulmonary thromboembolism (PTE) is rare but increasing, with significant recurrence and fatality rates. Further research is needed to refine estimates and inform prevention and management strategies for this condition.

Area of Science:

  • Pediatric Medicine
  • Cardiovascular Research
  • Epidemiology

Background:

  • Pulmonary thromboembolism (PTE) is a rare but life-threatening condition in children.
  • Pediatric PTE differs significantly from adult PTE in epidemiology and risk factors.
  • Understanding these differences is crucial for effective diagnosis and treatment.

Purpose of the Study:

  • To conduct a systematic review and meta-analysis on the epidemiology, clinical characteristics, and risk factors of pediatric PTE.
  • To summarize current knowledge and identify trends in pediatric PTE.
  • To inform future research and clinical practice.

Main Methods:

  • Systematic review and meta-analysis following PRISMA guidelines.
  • Searched eight databases for studies on pediatric PTE.
  • Included original studies reporting epidemiology, clinical characteristics, or risk factors; excluded reviews and case reports without epidemiological data.

Main Results:

  • 26 studies included, mostly of high quality.
  • Pooled incidence of pediatric PTE was 0.016%; autopsy-confirmed prevalence was 5.29%.
  • Case fatality was 4.04%, recurrence was 26.31%, with an increasing trend observed.

Conclusions:

  • Pediatric PTE is uncommon but increasing, with significant recurrence and fatality.
  • Further high-quality, population-based studies are needed to refine epidemiological estimates.
  • Clarifying age-specific risk profiles is essential for prevention and management.
Abstract

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.1K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
606
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
601
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
618
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308